#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Preventing urinary tract infections in infants and children under 2 years with oral Escherichia coli strain Nissle 1917 probiotic: a randomized controlled trial

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland

  • Study of blinatumomab plus drug combination in children and adolescents with acute lymphoblastic leukemia

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Intranasal remestemcel therapy for newborns with hypoxic‑ischemic brain injury: a phase II placebo‑controlled trial

    Not yet recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Safety and Tolerability Study of Subcutaneous Pegtibatinase in Adults and Children with Classical Homocystinuria (Phase 1/2)

    Not yet recruiting

    2 1 1
    France

  • Safety and Tolerability of Intrathecal ION337 in Patients with Dravet Syndrome

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Belgium France Germany Portugal Spain

  • Study of hu14.18K322A with temozolomide and irinotecan in children and adolescents with high‑risk neuroblastoma

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark France Germany Ireland Spain

  • Safety and Efficacy Study of FOXP3‑T4 and Aldesleukin in Patients with IPEX Syndrome

    Not yet recruiting

    1 1 1
    Investigated Drugs:
    France

  • Weekly Somatrogon versus Daily Somatropin in Children with Small for Gestational Age or Idiopathic Short Stature

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Greece Poland

  • Pharmacokinetics, Safety, and Immunogenicity of Subcutaneous Ocrelizumab in Children and Adolescents with Relapsing‑Remitting Multiple Sclerosis

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    France Germany Poland

  • Phase IIb Open‑Label Study of Intrathecal MELPIDA (AAV9/AP4M1) in Patients with Hereditary Spastic Paraplegia Type 50 (SPG50)

    Not yet recruiting

    2 1 1
    Denmark